Alan W. Lankester

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

C. Knechtli, Nicholas J. Goulden, Jeremy Hancock et al. · Blood · 1998 · 256 citations

Medicine, Hematology, Pediatrics +17

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

C. Knechtli, Nicholas J. Goulden, Jeremy Hancock et al. · British Journal of Haematology · 1998 · 111 citations

Medicine, Hematology, Immunology +16

Children With Acute Lymphoblastic Leukemia Who Receive T-Cell–Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome

Ann Green, Emer Clarke, Linda Hunt et al. · Blood · 1999 · 76 citations

Medicine, Hematology, Pediatrics +14

Directed Sibling Cord Blood Banking for Transplantation: The 10-Year Experience in the National Blood Service in England

Jon Smythe, Sue Armitage, Dorothy McDonald et al. · Stem Cells · 2007 · 51 citations

Medicine, Hematology, Cell Therapy +11

Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback

Suparno Chakrabarti, J Brown, M.G. Guttridge et al. · Bone Marrow Transplantation · 2003 · 49 citations

Life Sciences, Hematology, Immunology +13